Hvad er åbningstiderne?

Mandag 09:00 - 17:30 Tirsdag 09:00 - 17:30 Onsdag 09:00 - 17:30 Torsdag 09:00 - 17:30 Fredag 09:00 - 17:30

RetinaLyze International

Hjem
Danmark
Skovlunde
RetinaLyze International

Safe, fast and efficient retinal investigations with RetinaLyze AI and Telemedicine. Retinalyze is based on the vision to prevent loss of eyesight.

Worldwide diabetes is an increasing problem and +300 million registered diabetics (type 1 or 2) are expected in 2020. Furthermore by 2020 +250 million unregistered diabetics are expected. One of the most feared consequences of diabetes is retinal diabetic pathology since this can lead to blindness. Early diagnosis is crucial – and possible with Retinalyze. A good diabetic plan and a non-complicated laser treatment can prevent loss of sight and blindness. Our mission is to make it easier for people all over the world to have their eyes tested and prevent the tragic consequences caused by late treatment of retinal lesions. Retinalyze System A/S is a registered company in Denmark.

08/09/2025

Going to Denmark?

This year, RetinaLyze will be represented at ESCRS 2025 in Copenhagen by our very own Ganesh Ram and Teddy Birch Petersen.

Both will be on site to meet with eye care professionals, distributors, and partners who want to explore how AI and telemedicine can strengthen clinical workflows and support better patient outcomes.

If you’re attending ESCRS, don’t miss the chance to sit down with Ganesh and Teddy for a chat.

Are you curious about:
Expanding your services with AI-driven eye screening
Telemedical collaboration with ophthalmologists
Or new opportunities for distribution and partnership

👉 Book your meeting with Ganesh or Teddy here: https://calendly.com/d/cs3y-zpc-m3g/retinalyze-meeting-at-escrs

We’re looking forward to seeing many of you in our home city, Copenhagen. Welcome to Denmark!

04/09/2025

was fun! Next stop,

03/09/2025

To all the Brazilian followers! 👁🇧🇷

Discover how Artificial Intelligence is transforming glaucoma screening and diagnosis with RetinaLyze Glaucoma.

Join our Brazilian distributors interactive online training:
- September 4th | 18:00 (BRT)
- Live demonstration of the RetinaLyze system
- Interpretation of results and clinical indicators
- How to easily integrate into your clinical workflow
- Real cases + direct exchange with Prof. Dr. Roberto Lauande Pimentel

🎁 Register today and receive 30 days of free access to test the system!

Sign up now by scanning the QR code or visiting https://www.retinalyzebrasil.com.br/

Don’t forget to follow our Brazilian distributor here: RetinaLyze Brasil or on Instagram: https://www.instagram.com/retinalyze_brasil/

01/09/2025

Will you be at EURETINA this year? Let’s meet!

Teddy Birch Petersen and Ganesh Ram will be at EURETINA 2025 in Paris, and we’re excited to connect with eye care professionals, distributors, and industry partners from across the globe.

Our team will be ready to share how RetinaLyze combines AI, telemedicine, and education to make retinal screening faster, more accurate, and easier to integrate into daily practice.

👉 Whether you’re an optometrist looking to expand your services, an ophthalmologist interested in efficiency gains, or a distributor exploring new solutions for your market; We’d love to sit down with you.

🔗Book a meeting with us right here: https://calendly.com/d/cr74-frg-p6z/retinalyze-meeting-at-euretina

25/08/2025

🎉 Celebrating a wonderful partnership with TOMEY GmbH! 🎉

We're proud to support clinics and eye care professionals using the Tomey TFC-1000. A high-performance retinal camera that captures high-quality images in just 15 seconds.

Already trusted by a growing three-digit number of users, this joint solution continues to streamline eye screening across the industry!

With features like:
- Automatic eye tracking
- Auto focus and auto measurement
- 10fixation points
- Anterior segment imaging
the TFC-1000 makes capturing retinal images both quick and easy.

Transferring images to RetinaLyze happens completely automatically, thanks to the built-in computer. No extra hardware needed!

You'll save time and ease operation with the combination of the Tomey retinal camera and RetinaLyze.

Big thanks to our partners at Tomey for the strong collaboration and shared mission to simplify eye screening technology. 🙌

Interested in the Tomey TFC-1000?
Check out https://www.tomey.de/

Not using the Tomey TFC-1000?
Check out our list of 60+ compatible devices to see how we can work together: https://retinalyze.atlassian.net/wiki/spaces/HC/pages/707559599/Input+data+and+device+compatibility

18/08/2025

More time for what matters!

As highlighted in Review of Optometry, AI tools are transforming diabetic retinopathy detection, promising earlier diagnosis and broader access.

But: Our attitude is that AI doesn’t replace optometrists, it reshapes their role.

🔍 So, what can optometrists do to stay ahead?
Embrace AI as a clinical partner
AI can handle screening at scale. That gives you more time to focus on patients, education, and long-term care planning.

Train your team
Technicians and assistants play a key role in pre-screening. With RetinaLyze, they can confidently screen for signs of eye diseases such as DR, AMD and glaucoma, with AI delivering consistent results in seconds.

Build trust through transparency
Patients are curious (and sometimes skeptical) about AI. Show them how it supports your decisions. Don’t let the technology stay a black box.

Stay curious and critical
AI is a tool. Not gospel. Use your clinical judgment, experience, and patient context to guide final decisions.

At RetinaLyze System, we believe the future belongs to those who combine clinical insight with smart technology. It allows you to focus on the aspects of your work that matter the most to your customers/patients.

👉 Interested? Reach out for a free trial:
https://www.retinalyze.com/try

11/08/2025

Our glaucoma methodology is reaching the world and making an impact! 🌍

We are thrilled to share that our publication “Fully Automated Colorimetric Analysis of the Optic Nerve Aided by Deep Learning and Its Association with Perimetry and OCT for the Study of Glaucoma” (J. Clin. Med. 2021) has gained notable traction in the clinical and academic communities.

📊 Impact highlights as of July 2025:
🔍 3,428 views
📚 Citations: 19 Crossref, 19 WOS, 18 Scopus
🌐 Published in the Journal of Clinical Medicine
🧠 Median citation rate in the issue: 8

This work outlines our automated methodology to analyze the optic nerve using deep learning linking structural and functional glaucoma markers (OCT + perimetry) in a way that’s both scalable and practical.

A big thank you to the authors!

Marta Gonzalez-Hernandez, Daniel González Hernández, Daniel Pérez Barbudo, Paloma Rodríguez Esteve, Nisamar B.

And to Journal of Clinical Medicine (JCM) MDPI (MDPI) for providing a strong platform for open-access innovation.

If you're interested in early glaucoma detection, AI in ophthalmology, or telemedicine screening models, find the paper here:
👉 https://www.mdpi.com/2077-0383/10/15/3231

04/08/2025

Still stuck in the old days?

Say goodbye to manual uploads. RetinaLyze integrates seamlessly with your existing OCT and fundus imaging devices.

With our RetinaLyze Connect integration, retinal images and OCT scans are transferred directly to the RetinaLyze platform. Fast, secure, and fully automated.

✨ Device compatibility
Works effortlessly with imaging systems from Topcon, Canon, NIDEK, Tomey, Rodenstock Instruments, Heidelberg Engineering, ZEISS, Visionix, and others. No extra software gymnastics.

✨ Workflow efficiency
Images are automatically uploaded the moment they’re taken. No more SD cards, no more USB drives, no more drag-and-drop.

✨ Retina AI analysis at your fingertips
Once the images are uploaded, AI-powered screening for signs of Diabetic Retinopathy, AMD, and Glaucoma begins immediately. Your clinicians get results in seconds.

✨ Secure by design
RetinaLyze is CE-marked, ANVISA approved, registered with the UK MHRA and GDPR compliant. Your patients’ data stays private and protected.

✨ Minimal setup, maximum impact
Our team handles the integration setup in a matter of minutes. Your staff can focus entirely on patient care.

💬 Want to see how it works in your clinic?
Let’s connect: https://www.retinalyze.com/try

28/07/2025

Have you ever spotted small black dots on a retinal image and wondered whether they’re harmless or a sign of early disease?

In some cases, temporary retinal haemorrhages can appear after a feverish illness, heavy lifting, or even stress. They often disappear on their own. But the challenge lies in telling the temporary from the early signs of Diabetic Retinopathy (DR).

That’s where RetinaLyze comes in.

🟡A yellow result means we’ve detected minor lesions, such as a few hemorrhages or microaneurysms. It’s an early warning not a diagnosis. But it should be taken seriously if:
• The patient shows repeated yellow results over 2–3 months
• They report symptoms like blurred vision or dark spots
• They have a confirmed diabetes diagnosis

In these cases, yellow should be treated as red and the patient should be referred or followed up clinically.

💡On the other hand, if the patient is otherwise healthy, and there's reason to suspect artefacts or a temporary issue, a recheck in 2–3 months is usually a safe course of action. Always ensure high image quality to avoid false positives both for automated and manual assessments.

➡️ If you’re unsure, repeat the image. Trust your clinical instincts. RetinaLyze is here to guide you. Not replace your expertise.

21/07/2025

When was the last time someone looked deep into your eyes? 👀
If you had to think about it, it might be time for an eye check?

Optometrist Katrin Wagner and her team are combining expert guidance, personalized eyewear, and cutting-edge retinal screening – all in one visit.

We're proud to support partners like Brillenatelier in delivering better eye care every day.

Checkout what she offers below (German)!

RetinaLyze DACH, https://www.facebook.com/brillenatelier

14/07/2025

Over the past decade, AI and telemedicine have gone from buzzwords to real tools in modern optometry. But like any innovation, they come with both opportunities and trade-offs.

Let’s break it down:

✅ The Pros
• Early detection at scale. AI algorithms can help you detect eye conditions and abnormal retinas with consistency.
• Better access. Patients in rural or underserved areas can now get expert eye screenings without traveling.
• Efficiency boost, Clinics can screen more patients, reduce waiting times, and prioritize those who need a specialist consult.
• Data-driven insights. Longitudinal tracking and decision support make it easier to facilitate a deeper understanding the specific patient.

⚠️ The Cons
• False reassurance or alarm – AI is not perfect. There’s always a risk of over- or under-detection if not clinically validated and if the operator does not understand the tools they are using.
• Loss of the human touch. Eye care is about more than diagnostics; empathy and context matter.
• Integration headaches. Getting systems to talk to each other (EHRs, PMSs, imaging devices) is still a real challenge.
• Regulatory gray zones. Not all countries treat AI-assisted screenings equally.

Bottom line:
AI and telemedicine won’t replace optometrists or ophthalmologists but those who learn to work with these tools will likely set the new standard of care.

Adresse

Mileparken 10C
Skovlunde
2740

Åbningstider

Mandag	09:00 - 17:30
Tirsdag	09:00 - 17:30
Onsdag	09:00 - 17:30
Torsdag	09:00 - 17:30
Fredag	09:00 - 17:30

Internet side

https://retinalyze.com/

Underretninger

Vær den første til at vide, og lad os sende dig en email, når RetinaLyze International sender nyheder og tilbud. Din e-mail-adresse vil ikke blive brugt til andre formål, og du kan til enhver tid afmelde dig.

Kontakt Praksis

Send en besked til RetinaLyze International:

Genveje

Vil du plassere din praksis på toppen av Klinik-listen i Skovlunde?

Del

Prevention of blindness through AI

RetinaLyze prevents loss of eyesight by making eye screening accessible. 80% of all blindness is preventable. Early screening and diagnosis is crucial and possible with Retinalyze' automated retinal screening tools and telemedicine solutions. Our mission is to make it easier for people all over the world to have their eyes tested and prevent the tragic consequences caused by late treatment of retinal lesions.

RetinaLyze® is a screening software, which helps eye care professionals perform screenings for eye diseases in a safe and efficient manner. The automated algorithm (AI) module detects eye diseases by analyzing fundus images. It can be used as a clinical decision support system (CDSS) or as a screening tool in conjunction with the telemedicine module. Retinalyze System A/S is a registered company in Denmark. Check us out at https://RetinaLyze.com.